Technology | October 21, 2011

FDA Clears Segasist Prostate Auto-Contouring Treatment Planning Software

FDA Clears Segasist Prostate Auto-Contouring Treatment Planning Software

October 21, 2011 — Segasist Technologies, a Canadian software company, announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its prostate auto-contouring software Segasist P-AC. 

The software is a tool developed for the purpose of segmenting magnetic resonance (MR), computed tomography (CT) and ultrasound images of the prostate gland for diagnostic and treatment-planning purposes. It can be trained by individual clinicians to accurately and quickly process prostate images, including fast slice-by-slice auto-contouring and volumetric calculations.

It was externally validated at the London Health Sciences Centre (London, Ontario). Experts from the Sunnybrook Research Institute and Sunnybrook Health Sciences Centre (Toronto, Ontario) also participated in the validation process by providing input in the form of gold standard contours.

The current version of Segasist P-AC is a complete segmentation solution able to adjust the contouring process for prostate delineation in any modality. It can improve the segmentation result by adjusting its contouring techniques using images previously marked by the clinician. That gives the clinical expert the opportunity to use his own markings to train the software, even though the software can also be delivered pre-trained.

For more information: www.segasist.com

Related Content

RaySearch Developing RayCommand Treatment Control System for U.K. Proton Therapy Facility
Technology | Radiation Therapy | December 10, 2018
RaySearch has decided to develop a treatment control system, RayCommand, to act as a link between its RayStation...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Hypofractionated Radiation Provides Same Prostate Cancer Outcomes as Conventional Radiation
News | Intensity Modulated Radiation Therapy (IMRT) | October 31, 2018
An analysis led by researchers at Philadelphia’s Fox Chase Cancer Center found treating localized prostate cancer with...
Mirada Medical Showcases DLCExpert AI-Based Radiotherapy Contouring Software at ASTRO 2018
News | Treatment Planning | October 31, 2018
Medical imaging software company Mirada Medical showcased its DLCExpert at the recent American Society for Radiation...
Prostate Brachytherapy Shows Low Incidence of Short-Term Complications
News | Brachytherapy Systems | October 31, 2018
A new analysis of nearly 600 men receiving brachytherapy for prostate cancer shows overall procedure-related...
Elekta Introduces Strategy for Precision Radiation Medicine at ASTRO 2018

Elekta SmartClinic is one of the key features in the Mosaiq Plaza suite of data-focused integrative oncology software

News | Radiation Therapy | October 30, 2018
At the American Society for Radiation Oncology (ASTRO) Annual Meeting, Oct. 21-24 in San Antonio, Elekta introduced the...